Marie McDonnell, MD: New Basal Insulins for Type 2 Diabetes
Marie E. McDonnell, MD, of Brigham & Women's Hospital, Boston, Massachusetts, discusses implementing effective behavior change for patients with diabetes.
Medically supervised, therapeutic fasting regimens can help reverse type 2 diabetes (T2D) and minimize the need for pharmacological interventions.
Among U.S. women, a normally high circulating prolactin concentration is associated with a reduced risk for type 2 diabetes.
Greater variation of fasting plasma glucose over time is associated with an increased risk of developing type 2 diabetes.